Friday, Apr 26, 2024 | Last Update : 01:48 PM IST
Remdesivir Page-2
Gilead Sciences to start trials of inhaled version of remdesivir
The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19
23 Jun 2020 3:47 PM
Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir
Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila
14 Jun 2020 9:59 AM
Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19
It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma
13 Jun 2020 11:35 PM
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak
03 Jun 2020 11:57 AM
Despite FDA warning, Trump says he is taking hydroxychloroquine
The Food and Drug Administration has issued a warning about its use
19 May 2020 10:15 AM
Health groups want India to rescind Gilead drug patents
Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.
15 May 2020 11:46 AM
Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply
The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19
13 May 2020 8:44 AM
US allows use of remdesivir to help virus recovery
No drugs are currently FDA-approved for treating the coronavirus, and remdesivir will still need formal approval
02 May 2020 11:02 AM
US to roll back social distancing guidelines from tomorrow
Trump hopes to hold mass campaign rallies in the coming months, even though experts say there is little hope of having a vaccine by then
30 Apr 2020 10:29 AM
WHO Solidarity trial testing antiviral drug remdesivir, as it could stop coronavirus from replicating
In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require ventilator support
14 Apr 2020 1:51 PM
2 of 2
Columns
Analysis reveals Prime Minister Modi's diminishing impact as opposition highlights governance failures and divisive tactics.
Senior IPS Officer Y. Puran Kumar Raises Eyebrows with Complaint of Car Discrimination Amid Lok Sabha Elections
Modi's "Guarantee 2024" vs Congress' "Nyay Patra" - A Clash of Narratives
Exploring the historical context and implications of the term "Hindu Rashtra" in light of constitutional and legal frameworks.